SymBiosis Capital Partners, LLC Quant / Systematic

Location: Bentonville, AR

CIK: 0002006045 · Show all filings

Period: Q1 2026 (← Previous)

Filing Date: May 12, 2026

Total Value: $52.77M (100.0% shares, 0.0% debt)

Holdings (6)

New Positions (1)

WVE Wave Life Sciences Ltd. 10.3%

Value $5.438M Shares 750,000 Est. Cost $13.75 Unrealized 0.0%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
WVE	Wave Life Sciences Ltd.	750,000	$5.438M	10.3%	$13.75	0.0%	SHS	Y95308105

Exited Positions (6)

VSTM Verastem Inc 29.3%

Value $15.44M Shares 2,000,000 Est. Cost $8.91 Unrealized -27.3%

AMPG Aldeyra Therapeutics Inc 25.1%

Value $13.23M Shares 2,555,000 Est. Cost $3.38 Unrealized -4.9%

PGEN Precigen Inc 23.8%

Value $12.54M Shares 3,000,000 Est. Cost $3.87 Unrealized +16.3%

NUVB Nuvation Bio Inc 21.2%

Value $11.2M Shares 1,250,000 Est. Cost $6.19 Unrealized -0.1%

AARD Aardvark Therapeutics, Inc. 11.9%

Value $6.255M Shares 476,595 Est. Cost $12.48 Unrealized +8.7%

— Generation Bio Co 7.2%

Value $3.777M Shares 665,000 Est. Cost $5.68 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
VSTM	Verastem Inc	2,000,000	$15.44M	29.3%	$8.91	-27.3%	—	92337C203
AMPG	Aldeyra Therapeutics Inc	2,555,000	$13.23M	25.1%	$3.38	-4.9%	—	03211Q200
PGEN	Precigen Inc	3,000,000	$12.54M	23.8%	$3.87	+16.3%	—	74017N105
NUVB	Nuvation Bio Inc	1,250,000	$11.2M	21.2%	$6.19	-0.1%	—	67080N101
AARD	Aardvark Therapeutics, Inc.	476,595	$6.255M	11.9%	$12.48	+8.7%	—	002942100
—	Generation Bio Co	665,000	$3.777M	7.2%	$5.68	—	—	37148K209

Decreased Positions (3)

RANI Rani Therapeutics Holdings, Inc. 5.1%

Value $2.695M (-68.3%) Shares 3,667,585 (-41.8%) Est. Cost $1.51 Unrealized -12.3%

CLNN Clene Nanomedicine Inc. 4.0%

Value $2.125M (-53.0%) Shares 431,094 (-44.0%) Est. Cost $8.31 Unrealized -41.2%

IVA Inventiva S.A. 24.8%

Value $13.06M (+8.1%) Shares 2,354,000 (-9.5%) Est. Cost $4.65 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
RANI	Rani Therapeutics Holdings, Inc.	3,667,585 (-41.8%)	$2.695M (-68.3%)	5.1%	$1.51	-12.3%	COM CL A	753018100
CLNN	Clene Nanomedicine Inc.	431,094 (-44.0%)	$2.125M (-53.0%)	4.0%	$8.31	-41.2%	COM NEW	185634201
IVA	Inventiva S.A.	2,354,000 (-9.5%)	$13.06M (+8.1%)	24.8%	$4.65	—	ADS	46124U107

Unchanged Positions (2)

EVMN Evommune, Inc. 55.8%

Value $29.45M Shares 1,280,778 Est. Cost $18.78 Unrealized +17.1%

SRZNW Surrozen, Inc. 0.0%

Value $2,400 Shares 150,000 Est. Cost $0.02 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
EVMN	Evommune, Inc.	1,280,778	$29.45M	55.8%	$18.78	+17.1%	COM SHS	30054Y107
SRZNW	Surrozen, Inc.	150,000	$2,400	0.0%	$0.02	—	*W EXP 08/01/203	86889P117